Cargando…

The incidence of venous thromboembolism in cervical cancer: a nationwide population-based study

BACKGROUND: Venous thromboembolism (VTE) is a life-threatening condition that occurs as a complication of cervical cancer. The aim of this study was to evaluate the incidence of VTE in cervical cancer patients during a 5-year follow-up. METHODS: The study analyzed data deposited between 2003 and 200...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Shiang-Jiun, Ruan, Ying-Xu, Lee, Ching-Chih, Lee, Moon-Sing, Chiou, Wen-Yen, Lin, Hon-Yi, Hsu, Feng-Chun, Su, Yu-Chieh, Hung, Shih-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410881/
https://www.ncbi.nlm.nih.gov/pubmed/22721503
http://dx.doi.org/10.1186/1756-0500-5-316
_version_ 1782239778366816256
author Tsai, Shiang-Jiun
Ruan, Ying-Xu
Lee, Ching-Chih
Lee, Moon-Sing
Chiou, Wen-Yen
Lin, Hon-Yi
Hsu, Feng-Chun
Su, Yu-Chieh
Hung, Shih-Kai
author_facet Tsai, Shiang-Jiun
Ruan, Ying-Xu
Lee, Ching-Chih
Lee, Moon-Sing
Chiou, Wen-Yen
Lin, Hon-Yi
Hsu, Feng-Chun
Su, Yu-Chieh
Hung, Shih-Kai
author_sort Tsai, Shiang-Jiun
collection PubMed
description BACKGROUND: Venous thromboembolism (VTE) is a life-threatening condition that occurs as a complication of cervical cancer. The aim of this study was to evaluate the incidence of VTE in cervical cancer patients during a 5-year follow-up. METHODS: The study analyzed data deposited between 2003 and 2008 in the National Health Insurance Research Database (NHIRD), provided by the National Health Research Institutes in Taiwan. Totally, 1013 cervical cancer patients after treatment and 2026 appendectomy patients were eligible. The Kaplan-Meier method and the Cox proportional hazards model were used to assess the VTE risk. RESULTS: The 5-year cumulative risk for VTE was significantly higher in the cervical cancer group than in the control group (3.3% vs 0.3%, p < 0.001). The hazard ratio for VTE was 10.14 times higher in the cervical cancer group than in the controls. The combined presence of more comorbidities was associated with a higher risk for VTE. Furthermore, cervical cancer patients without VTE had a significantly higher survival (75.3% vs 30.3%, p < 0.001). CONCLUSIONS: The cumulative risk of VTE was significantly higher in cervical cancer patients, and these patients also had lower survival rates. Strategies to reduce these risks need to be examined.
format Online
Article
Text
id pubmed-3410881
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34108812012-08-03 The incidence of venous thromboembolism in cervical cancer: a nationwide population-based study Tsai, Shiang-Jiun Ruan, Ying-Xu Lee, Ching-Chih Lee, Moon-Sing Chiou, Wen-Yen Lin, Hon-Yi Hsu, Feng-Chun Su, Yu-Chieh Hung, Shih-Kai BMC Res Notes Research Article BACKGROUND: Venous thromboembolism (VTE) is a life-threatening condition that occurs as a complication of cervical cancer. The aim of this study was to evaluate the incidence of VTE in cervical cancer patients during a 5-year follow-up. METHODS: The study analyzed data deposited between 2003 and 2008 in the National Health Insurance Research Database (NHIRD), provided by the National Health Research Institutes in Taiwan. Totally, 1013 cervical cancer patients after treatment and 2026 appendectomy patients were eligible. The Kaplan-Meier method and the Cox proportional hazards model were used to assess the VTE risk. RESULTS: The 5-year cumulative risk for VTE was significantly higher in the cervical cancer group than in the control group (3.3% vs 0.3%, p < 0.001). The hazard ratio for VTE was 10.14 times higher in the cervical cancer group than in the controls. The combined presence of more comorbidities was associated with a higher risk for VTE. Furthermore, cervical cancer patients without VTE had a significantly higher survival (75.3% vs 30.3%, p < 0.001). CONCLUSIONS: The cumulative risk of VTE was significantly higher in cervical cancer patients, and these patients also had lower survival rates. Strategies to reduce these risks need to be examined. BioMed Central 2012-06-21 /pmc/articles/PMC3410881/ /pubmed/22721503 http://dx.doi.org/10.1186/1756-0500-5-316 Text en Copyright ©2012 Tsai et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tsai, Shiang-Jiun
Ruan, Ying-Xu
Lee, Ching-Chih
Lee, Moon-Sing
Chiou, Wen-Yen
Lin, Hon-Yi
Hsu, Feng-Chun
Su, Yu-Chieh
Hung, Shih-Kai
The incidence of venous thromboembolism in cervical cancer: a nationwide population-based study
title The incidence of venous thromboembolism in cervical cancer: a nationwide population-based study
title_full The incidence of venous thromboembolism in cervical cancer: a nationwide population-based study
title_fullStr The incidence of venous thromboembolism in cervical cancer: a nationwide population-based study
title_full_unstemmed The incidence of venous thromboembolism in cervical cancer: a nationwide population-based study
title_short The incidence of venous thromboembolism in cervical cancer: a nationwide population-based study
title_sort incidence of venous thromboembolism in cervical cancer: a nationwide population-based study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410881/
https://www.ncbi.nlm.nih.gov/pubmed/22721503
http://dx.doi.org/10.1186/1756-0500-5-316
work_keys_str_mv AT tsaishiangjiun theincidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy
AT ruanyingxu theincidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy
AT leechingchih theincidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy
AT leemoonsing theincidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy
AT chiouwenyen theincidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy
AT linhonyi theincidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy
AT hsufengchun theincidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy
AT suyuchieh theincidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy
AT hungshihkai theincidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy
AT tsaishiangjiun incidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy
AT ruanyingxu incidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy
AT leechingchih incidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy
AT leemoonsing incidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy
AT chiouwenyen incidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy
AT linhonyi incidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy
AT hsufengchun incidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy
AT suyuchieh incidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy
AT hungshihkai incidenceofvenousthromboembolismincervicalcanceranationwidepopulationbasedstudy